Neuropore Therapies,Inc。announced that it received a $4.8M grant from The Michael J. Fox Foundation for Parkinson’s Research.The grant will be used to support the preclinical and clinical development a of a novel brain-penetrating small molecule Toll-Like receptor 2 (TLR2) antagonist.